Mobile Cardiac Outpatient Telemetry Patch vs Implantable Loop Recorder in Cryptogenic Stroke Patients in the US - Cost-Minimization Model.

IF 1.3 Q4 ENGINEERING, BIOMEDICAL
Medical Devices-Evidence and Research Pub Date : 2021-12-18 eCollection Date: 2021-01-01 DOI:10.2147/MDER.S337142
Goran Medic, Nikos Kotsopoulos, Mark P Connolly, Jennifer Lavelle, Vincent Norlock, Manish Wadhwa, Belinda A Mohr, Wayne M Derkac
{"title":"Mobile Cardiac Outpatient Telemetry Patch vs Implantable Loop Recorder in Cryptogenic Stroke Patients in the US - Cost-Minimization Model.","authors":"Goran Medic,&nbsp;Nikos Kotsopoulos,&nbsp;Mark P Connolly,&nbsp;Jennifer Lavelle,&nbsp;Vincent Norlock,&nbsp;Manish Wadhwa,&nbsp;Belinda A Mohr,&nbsp;Wayne M Derkac","doi":"10.2147/MDER.S337142","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to compare costs and outcomes of mobile cardiac outpatient telemetry (MCOT) patch followed by implantable loop recorder (ILR) compared to ILR alone in cryptogenic stroke patients from the US health-care payors' perspective.</p><p><strong>Patients and methods: </strong>A quantitative decision tree cost-minimization simulation model was developed. Eligible patients were 18 years of age or older and were diagnosed with having a cryptogenic stroke, without previously documented atrial fibrillation (AF). All patients were assigned first to one then to the alternative monitoring strategies. Following AF detection, patients were initiated on oral anticoagulants (OAC). The model assessed direct costs for one year attributed to MCOT patch followed by ILR or ILR alone using a monitoring duration of 30 days post-cryptogenic stroke.</p><p><strong>Results: </strong>In the base case modeling, the MCOT patch arm detected 4.6 more patients with AFs compared to the ILR alone arm in a cohort of 1000 patients (209 vs 45 patients with detected AFs, respectively). Using MCOT patch followed by ILR in half of the patients initially undiagnosed with AF leads to significant cost savings of US$4,083,214 compared to ILR alone in a cohort of 1000 patients. Cost per patient with detected AF was significantly lower in the MCOT patch arm $29,598 vs $228,507 in the ILR only arm.</p><p><strong>Conclusion: </strong>An initial strategy of 30-day electrocardiogram (ECG) monitoring with MCOT patch in diagnosis of AF in cryptogenic stroke patients realizes significant cost-savings compared to proceeding directly to ILR only. Almost 8 times lower costs were achieved with improved detection rates and reduction of secondary stroke risk due to new anticoagulant use in subjects with MCOT patch detected AF. These results strengthen emerging recommendations for prolonged ECG monitoring in secondary stroke prevention.</p>","PeriodicalId":47140,"journal":{"name":"Medical Devices-Evidence and Research","volume":"14 ","pages":"445-458"},"PeriodicalIF":1.3000,"publicationDate":"2021-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/69/94/mder-14-445.PMC8694406.pdf","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Devices-Evidence and Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/MDER.S337142","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 5

Abstract

Purpose: The aim of this study was to compare costs and outcomes of mobile cardiac outpatient telemetry (MCOT) patch followed by implantable loop recorder (ILR) compared to ILR alone in cryptogenic stroke patients from the US health-care payors' perspective.

Patients and methods: A quantitative decision tree cost-minimization simulation model was developed. Eligible patients were 18 years of age or older and were diagnosed with having a cryptogenic stroke, without previously documented atrial fibrillation (AF). All patients were assigned first to one then to the alternative monitoring strategies. Following AF detection, patients were initiated on oral anticoagulants (OAC). The model assessed direct costs for one year attributed to MCOT patch followed by ILR or ILR alone using a monitoring duration of 30 days post-cryptogenic stroke.

Results: In the base case modeling, the MCOT patch arm detected 4.6 more patients with AFs compared to the ILR alone arm in a cohort of 1000 patients (209 vs 45 patients with detected AFs, respectively). Using MCOT patch followed by ILR in half of the patients initially undiagnosed with AF leads to significant cost savings of US$4,083,214 compared to ILR alone in a cohort of 1000 patients. Cost per patient with detected AF was significantly lower in the MCOT patch arm $29,598 vs $228,507 in the ILR only arm.

Conclusion: An initial strategy of 30-day electrocardiogram (ECG) monitoring with MCOT patch in diagnosis of AF in cryptogenic stroke patients realizes significant cost-savings compared to proceeding directly to ILR only. Almost 8 times lower costs were achieved with improved detection rates and reduction of secondary stroke risk due to new anticoagulant use in subjects with MCOT patch detected AF. These results strengthen emerging recommendations for prolonged ECG monitoring in secondary stroke prevention.

Abstract Image

Abstract Image

美国隐源性脑卒中患者的移动心脏门诊遥测贴片vs植入式循环记录仪-成本最小化模型。
目的:本研究的目的是比较从美国医疗保健支付者的角度来看,在隐源性卒中患者中,移动心脏门诊遥测(MCOT)贴片加植入式环路记录仪(ILR)与单独使用ILR的成本和结果。患者和方法:建立了定量决策树成本最小化仿真模型。符合条件的患者为18岁或以上,诊断为隐源性卒中,既往无房颤(AF)记录。所有患者首先被分配到一种监测策略,然后被分配到替代监测策略。房颤检测后,患者开始口服抗凝剂(OAC)。该模型评估了MCOT贴片随后ILR或单独ILR的一年直接成本,监测时间为隐源性卒中后30天。结果:在基础病例模型中,在1000例患者队列中,MCOT贴片组检测到的AFs患者比单独使用ILR组多4.6例(分别为209例和45例检测到AFs)。在一组1000名患者中,一半最初未诊断为房颤的患者使用MCOT贴片后再使用ILR,与单独使用ILR相比,可显著节省4083214美元的费用。MCOT贴片组检测到的每位AF患者的成本为29,598美元,而仅ILR贴片组为228,507美元。结论:与直接进行ILR相比,使用MCOT贴片进行30天心电图监测诊断隐源性卒中患者房颤的初步策略可显着节省成本。在MCOT贴片检测到AF的受试者中使用新的抗凝剂,提高了检出率,降低了继发性卒中风险,成本降低了近8倍。这些结果加强了在继发性卒中预防中延长ECG监测的新建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical Devices-Evidence and Research
Medical Devices-Evidence and Research ENGINEERING, BIOMEDICAL-
CiteScore
2.80
自引率
0.00%
发文量
41
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信